|
Throughout her career, Virginia has managed a wide range of projects spanning the lifecycle of biopharmaceutical firms:
Startup Origination – technical due diligence, identification and evaluation of intellectual property, business planning, leadership recruitment and business model development and implementation;
Early stage fundings – due diligence and business viability assessments; and
Growth firms – fund-raising strategy development and presentation, executive coaching, technology evaluation and acquisition, business strategy and execution including business development and corporate partnering.
Virginia completed her undergraduate education at the University of Michigan where she received her BS (Honors) in Cellular and Molecular Biology, and did her doctoral work in Biology at Yale University, specializing in molecular genetics. She did post-doctoral work in Immunology at Bristol Myers Squibb.
In 1990 Virginia joined the Branford, CT based biotechnology consulting firm, Scheer & Company where she became Vice President in 1996. There, Virginia led a broad range of projects for both investors and companies throughout the biopharmaceutical industry. In 2000, she left Scheer & Company to start Herndon Company where she continues to offer a broad range of consulting services to both companies and investors.
Virginia’s achievements include.
|